{
  "id": "5e5409776d0a277941000051",
  "type": "factoid",
  "question": "What is AZD0530 an inhibitor of?",
  "ideal_answer": "AZD0530 is a highly selective, dual Src/Abl kinase inhibitor.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/22623106"
  ],
  "snippets": [
    {
      "text": "Saracatinib, a highly selective, dual Src/Abl kinase inhibitor, is currently in a Phase II clinical trial for the treatment of ovarian cancer.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22623106",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "dual Src/Abl kinase"
}